
HEMAB THERAPEUTICS HOLDINGS
COAG · NASDAQ
Updated at 2026-11-16 20:42:47
- Today's High
- $42.08
- Today’s Low
- $38.13
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $39.37
- Previous Close
- $40.86
- Volume
- 401.08K
- Market Cap
- $1.9B
- P/E Ratio
- --
- EPS
- --
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 101 MAIN STREET, CAMBRIDGE, MA, UNITED STATES, 02142
- Country
- US
- Listing Date
- 2026-05-01
- Fiscal Year End
- December
- Shares Outstanding
- 46.71M
- CIK
- 0002114044
- Website
- ir.hemab.com
Hemab Therapeutics Holdings, Inc. (Ticker: COAG) is a pioneering biopharmaceutical company dedicated to developing innovative therapies for rare bleeding disorders and other hematologic conditions. With a proprietary technology platform and a strong pipeline of drug candidates, Hemab aims to address significant unmet medical needs in hematology. The company's commitment to rigorous research and development, complemented by strategic partnerships, positions it favorably within the fast-evolving biotechnology landscape. Hemab's mission to enhance patient outcomes underscores its potential as an attractive investment opportunity for institutional investors seeking to capitalize on advancements in this critical healthcare sector.
Financial Metrics
Revenue
2026-09-30
$0
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
Operating Expenses
2026-09-30
$29.75M
2026-06-30
$26.07M
2026-03-31
$23.61M
2025-12-31
$20.44M
Net Income
2026-09-30
-$27.3M
2026-06-30
-$24.15M
2026-03-31
-$22.68M
2025-12-31
-$19.33M
Net Profit Margin
2026-09-30
--
2026-06-30
--
2026-03-31
--
2025-12-31
--
Earnings Per Share
2026-09-30
$-0.58
2026-06-30
$-0.80
2026-03-31
$-0.48
2025-12-31
--
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-09-30
-$26.53M
2026-06-30
-$26M
2026-03-31
-$23.53M
2025-12-31
-$20.37M
Effective Tax Rate
2026-09-30
-2.6%
2026-06-30
-0.4%
2026-03-31
-0.05%
2025-12-31
0.71%
| Item | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $29.75M | $26.07M | $23.61M | $20.44M |
| Net Income | -$27.3M | -$24.15M | -$22.68M | -$19.33M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.58 | $-0.80 | $-0.48 | -- |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$26.53M | -$26M | -$23.53M | -$20.37M |
| Effective Tax Rate | -2.6% | -0.4% | -0.05% | 0.71% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.